The healthcare sector is outperforming the broader market and tech sector in Q4, confirming a substantial capital shift into ...

"Eli Lilly picks Alabama as home to $6bn orforglipron manufacturing facility" was originally created and published by ...

reported better-than-expected earnings for the fourth quarter. The Indianapolis, Indiana-based company posted quarterly earnings of $428.5 million, or $0.40 per share, compared to $727.5 million, or ...

Eli Lilly stock (NYSE: LLY) is up 10% this month, a rise driven by strong clinical trial progress. This includes the announcement of positive Phase 3 results in October 2025 for its oral GLP-1 drug, ...

Eli Lilly to invest $6 billion in new synthetic medicine facility in Huntsville, AL to boost domestic production and create ...

Eli Lilly's shares may appear expensive at first glance, but a closer look reveals a different story. The company's outlook is strong, and the stock is a buy, even at current levels. Eli Lilly's (NYSE ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.